124 related articles for article (PubMed ID: 7737222)
1. Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety.
Shepherd J
Eur Heart J; 1995 Jan; 16(1):5-13. PubMed ID: 7737222
[No Abstract] [Full Text] [Related]
2. Statins and fibrates in the management of diabetic dyslipidemia.
Durrington P
Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
[No Abstract] [Full Text] [Related]
3. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
Martínez-Castelao A
Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
[No Abstract] [Full Text] [Related]
4. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
Carmena R
Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
[No Abstract] [Full Text] [Related]
5. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin.
Emmerich J
Am J Cardiol; 1994 Apr; 73(9):723-4. PubMed ID: 8166080
[No Abstract] [Full Text] [Related]
6. Efficacy of low-density-lipoprotein lowering with statins.
Rosenson RS; Stein JH
Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
[No Abstract] [Full Text] [Related]
7. Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.
Freeman SR; Drake AL; Heilig LF; Graber M; McNealy K; Schilling LM; Dellavalle RP
J Natl Cancer Inst; 2006 Nov; 98(21):1538-46. PubMed ID: 17077356
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
[No Abstract] [Full Text] [Related]
9. Hyperlipidaemia and cardiovascular disease.
Le NA
Curr Opin Lipidol; 2001 Oct; 12(5):587-9. PubMed ID: 11561179
[No Abstract] [Full Text] [Related]
10. Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry.
Ballantyne CM; Bourge RC; Domalik LJ; Eisen HJ; Fishbein DP; Kubo SH; Lake KD; Radovancevic B; Taylor DO; Ventura HO; Yancy CW; Young JB
Am J Cardiol; 1996 Sep; 78(5):532-5. PubMed ID: 8806337
[TBL] [Abstract][Full Text] [Related]
11. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.
Illingworth DR; Erkelens DW; Keller U; Thompson GR; Tikkanen MJ
Lancet; 1994 Jun; 343(8912):1554-5. PubMed ID: 7911877
[No Abstract] [Full Text] [Related]
12. Efficacy of low-density-lipoprotein lowering with statins.
Seidel D; Cremer P
Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915367
[No Abstract] [Full Text] [Related]
13. Pravastatin and simvastatin for hypercholesterolemia.
Med Lett Drugs Ther; 1991 Mar; 33(839):18-20. PubMed ID: 1899899
[No Abstract] [Full Text] [Related]
14. Management of non-nephrotic hyperlipidaemia of chronic renal failure with simvastatin.
Harris DC; Simons LA; Mitchell P; Stewart JH
Med J Aust; 1991 Oct; 155(8):573. PubMed ID: 1943943
[No Abstract] [Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
Golay A; Lehmann T; James R; Pometta D
Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin versus simvastatin--what happens in the real world?
Levenstein S
S Afr Med J; 1995 May; 85(5):388-91. PubMed ID: 7638696
[No Abstract] [Full Text] [Related]
18. Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.
Farnier M; Retterstøl K; Steinmetz A; Császár A
Diab Vasc Dis Res; 2012 Jul; 9(3):205-15. PubMed ID: 22228773
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
Hsu I; Spinler SA; Johnson NE
Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
[TBL] [Abstract][Full Text] [Related]
20. Statins do more than just lower cholesterol.
Vaughan CJ; Murphy MB; Buckley BM
Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463
[No Abstract] [Full Text] [Related]
[Next] [New Search]